An interventional study of Possibility to get live attenuated nasal influenza vaccine at daycare in Influenza Vaccination, sponsored by Turku University Hospital. Recruiting at 1 site in Finland. Open to participants aged 2 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-22.
Sponsored by Turku University Hospital · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Influenza, Human with a site in Finland — 3 open to participants now, 3 under way, 1 of them phase 3. Influenza, Human · Finland.
Among the 43 studies in Influenza, Human with a site in Finland, this one is the 10th largest by planned enrollment of the 37 interventional ones that give a count, is one of 2 that started in 2025, is one of 2 with no phase, and was the 43rd registered.
2,361 studies on the registry are indexed under Influenza, Human; 186 are open to participants now.
Browse Influenza, Human studies →3 of the 43 studies in Influenza, Human with a site in Finland are open now. Recruiting first, the newest first:
Finnish Institute for Health and Welfare · Sites in Finland
Ages 18–64 · Healthy volunteers
UMC Utrecht · Sites in Finland, United States, Australia and 26 more countries
Ages 28 days+
A study can be open while its sites in Finland have not opened yet or have stopped. Only those recruiting at a site in Finland →
Of the 124 Influenza, Human studies recruiting now, 67 (54%) set no upper age limit and 47 (38%) stop at 75 or younger; 34 take children under 18; 69 take healthy volunteers.
This study: 2 Years to 6 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 11 · Phase 3 20 · Phase 4 4
First in 1999; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 6,000 is above the median of 228 across 1,959 interventional studies indexed under Influenza, Human.
Median enrollment 807 across the 37 interventional studies, 1,941 across the 6 observational. Of the 39 that completed or were terminated, 15 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
35 of 43 have an industry lead sponsor. The 10 most frequent:
Turku University Hospital is the lead sponsor of 288 studies on the registry; 67 are open to participants now.
Turku University Hospital has 2 studies filed under Influenza, Human — fewer than ten, so there is no comparison to draw.
1 of the studies in Influenza, Human with a site in Finland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03323112Finnish Institute for Health and WelfareImmune Responses in Health Care Personnel | 2027-10-14 |
Add it to your calendar (.ics) → With an account.
Among the 43 studies in Influenza, Human with a site in Finland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this intervention study is to learn if giving children influenza vaccinations in early childhood education facilities (i.e., daycare) will increase vaccination coverage compared to giving vaccinations only at healthcare. The main question it aims to answer is:
Researchers will compare daycare setting and healthcare setting as the location of giving influenza vaccines to children to see if more children will get vaccinated if they have an opportunity to receive nasal influenza vaccine at daycare.
Participants in the intervention group will:
Participants in the comparison group will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants are offered a nasal influenza vaccine at daycare
Behavioral: Possibility to get live attenuated nasal influenza vaccine at daycare
Participants are not offered a nasal influenza vaccine at daycare
The intervention is the possibility to get influenza vaccine in the daycare, in comparison to routine practice of getting influenza vaccine in a healthcare setting.
Influenza vaccination coverage
Study child receiving any influenza vaccine
Time frame: From enrollment to the end of seasonal influenza vaccinations about 3 to 10 weeks later.
Plan to share: No — According to national regulations, it is not allowed to share individual health data.
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Mar 2026, 5 months after the start.
Of 147 non-industry interventional studies with no phase under Influenza, Human, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 18. This study's planned 5 months is below that.
Counting every sponsor, half of 167 studies reached it within 6 months; a quarter within 3 and three quarters within 16.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.